SPECIFICATIONS |
|
| Product Name | Sarpogrelate hydrochloride |
| CAS NO. | 135159-51-2 |
| EINECS No. | 663-199-9 |
| Molecular Formula | C24H32ClNO6 |
| Molecular Mass | 465.96698 |
| Assay | 99% |
| Appearance(pending) | solid |
Applications by Fields
-
Pharmaceutical Field
- Antiplatelet agent: Sarpogrelate hydrochloride is primarily used to treat cardiovascular diseases such as coronary artery disease and angina pectoris by inhibiting platelet aggregation, reducing thrombus formation, and lowering the risk of vascular blockage.
- Antithrombotic therapy: It is commonly employed to prevent thrombotic diseases caused by atherosclerosis, including stroke and myocardial infarction.
- Diabetes-related vascular complications: Used to treat vascular issues caused by diabetes, especially to improve microcirculation and reduce thrombotic risk.
-
Clinical Applications
- Prevention of surgical complications: Used postoperatively, particularly after cardiac surgery, to prevent thrombus formation.
- Combination therapy: Often combined with other antiplatelet drugs to enhance antithrombotic effects, especially in high-risk patients.



